Evaluates the intrinsic coagulation pathway (FXII, FXI, FIX, FVIII) and common pathway. Extended in haemophilia A (FVIII) and B (FIX), lupus anticoagulant, and heparin therapy.
| Sex | Age | Range | Notes |
|---|---|---|---|
| All | ≥ 18 yrs | 23 – 35 | Adult; lab-specific ratio APTT/control also reported |
⚠ Clinical Note
Reference ranges are indicative. Always interpret results in the context of the individual patient and local laboratory reference intervals, which may vary.